James Karrels
2021
In 2021, James Karrels earned a total compensation of $1.9M as Senior Vice President, Chief Financial Officer and Corporate Secretary at MacroGenics, a 52% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,295 |
|---|---|
| Option Awards | $1,328,091 |
| Salary | $431,908 |
| Other | $8,700 |
| Total | $1,905,994 |
Karrels received $1.3M in option awards, accounting for 70% of the total pay in 2021.
Karrels also received $137.3K in non-equity incentive plan, $431.9K in salary and $8.7K in other compensation.
Rankings
In 2021, James Karrels' compensation ranked 6,214th out of 12,415 executives tracked by ExecPay. In other words, Karrels earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,214 out of 12,415 | 50th |
Division Manufacturing | 2,633 out of 5,505 | 52nd |
Major group Chemicals And Allied Products | 1,151 out of 2,375 | 52nd |
Industry group Drugs | 1,023 out of 2,096 | 51st |
Industry Pharmaceutical Preparations | 741 out of 1,546 | 52nd |
Source: SEC filing on April 8, 2022.
Karrels' colleagues
We found four more compensation records of executives who worked with James Karrels at MacroGenics in 2021.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020